Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
about
Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysisTemozolomide: a milestone in neuro-oncology and beyond?[Adjuvant radiochemotherapy in the elderly affected by glioblastoma: single-institution experience and literature review].Radiation therapy for older patients with brain tumorsTemozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.Management of elderly patients with gliomasTowards personalized therapy for patients with glioblastoma.New developments in the treatment of malignant gliomas.Management of glioblastoma.Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectivePalliative treatment of poor prognosis patients with malignant gliomas.Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy.Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma.High-grade glioma in elderly patients: can the oncogeriatrician help?Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.Elderly patients with glioblastoma: the treatment challenge.Treatment of malignant gliomas in elderly patients: a concise overview of the literature.Treating glioblastoma patients with poor performance status: where do we go from here?Treating glioblastoma in the elderly.Radiation therapy for older adults with glioblastoma: radical treatment, palliative treatment, or no treatment at all?The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Glioblastoma care in the elderly.Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system.Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status.Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival.Radiotherapy with and without temozolomide in elderly patients with glioblastoma.Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.SEOM guideline for the treatment of malignant glioma.A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients.Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study.Primary brain tumors in the elderly population.Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme
P2860
Q28088458-DA0CBBED-536D-4456-B4F0-5A9EC42CC588Q33372340-6B1C6EC3-B1A4-45C2-AD95-02B06497E377Q33404566-FC47FB9E-D5DC-4A99-BCD6-A68BE5936271Q33815025-57C4ECF0-A8F8-48BE-B6A3-B1B1024FAE01Q33973844-08410770-8A64-48E3-A564-7A26A94F5539Q34295064-89F0D4D8-55A8-4495-98D5-D541D2E4399BQ34641001-B8C6A7D2-2266-49D9-A4BF-33CC0217601DQ34978252-92570DC7-1701-42FE-99A0-3D986BAB0B12Q36972696-039ECBEB-5F6F-4E83-AB70-593405370DA4Q37013025-B3B7F6CF-8873-42DB-A1E3-84E1AF37EEB8Q37021557-58352927-2A72-4EFB-B96C-F50963DA47D6Q37038922-FCAA662C-96C0-4DFD-888A-8A7DC36C47C7Q37159513-703DD618-3B13-4DF2-82C0-0B07A97093F0Q37226536-C4F40832-DC2D-482F-9CE5-A5715EA6FFF6Q37237358-88455E46-9652-4BEC-8D60-0A3D9549B5E5Q37388217-291AC40C-FAC5-4169-86CF-69C7FF16F76AQ37628704-4AD06FFD-D9E1-4C40-9DBB-C3ECD22E9A89Q37959367-CEB2008D-8A1B-4E16-8682-6D6026595781Q38151772-EDA8C7AA-8AB1-4DA1-9357-8C999A4809E9Q38215192-8353C5C4-6E73-4DFA-A12C-3B80FC41030AQ38233183-EE0F2F76-CDB4-462F-973D-341B571CC080Q38233427-45A512A5-E741-48E0-A104-520DDBA1089DQ38237311-9958097C-1674-4865-AC79-31ACA383EA58Q38255481-436AF220-3539-4F3D-95B3-61838F1AB52AQ38653138-8C6F37CF-5D88-4B64-AA46-DD4A1FEB81B6Q39583530-06AA0B3A-331B-4565-BD94-CF8BBC86FEABQ43542819-C3A335F9-263D-43A8-8F41-453EA7E2FD1AQ43952711-EE4ED237-02E8-47D3-B819-C665E331E3F5Q44220822-6DF96297-7748-4EF2-B3A7-F3E5B951BEC5Q48099567-76C27B23-0942-4567-8BBE-422E9593B7B4Q48161996-D7F9F1B1-5227-42BB-B6B8-5664782A7010Q48464940-DD20B084-EBE7-46E5-BCDE-1C4AE89ECDB7Q48901436-057FFE8B-7259-463D-8235-EE59B19188E1Q48905126-B0026511-B876-4A51-9E9F-2CC9975D2BEEQ53083081-A9579048-871C-4E1A-B5CC-1C26AEEA83A4Q55460926-FC4ABEA4-D627-4628-A790-369DA2339272Q55461155-994308A5-CC29-4B13-A65E-C3D64AE3A46DQ56453569-40869CEE-56FB-4ABA-91F2-DF5F436D69C6
P2860
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase II study of temozolomide ...... rme in an elderly populations.
@ast
Phase II study of temozolomide ...... rme in an elderly populations.
@en
type
label
Phase II study of temozolomide ...... rme in an elderly populations.
@ast
Phase II study of temozolomide ...... rme in an elderly populations.
@en
prefLabel
Phase II study of temozolomide ...... rme in an elderly populations.
@ast
Phase II study of temozolomide ...... rme in an elderly populations.
@en
P2093
P356
P1433
P1476
Phase II study of temozolomide ...... rme in an elderly populations.
@en
P2093
Elisabeth Frauger
François Grisoli
Henry Dufour
Jacky Palmari
Jean-Claude C Peragut
Karima Moktari
Khe Hoang-Xuan
Maryline Barrie
Olivier-L Chinot
P2860
P304
P356
10.1002/CNCR.20224
P407
P577
2004-05-01T00:00:00Z